What Enhanced charges
Enhanced charges $59/month for its microdose tier; its standard plans start at $89/month and hold that rate across every dose.
- Compounded semaglutide (monthly): $129/month
- Compounded semaglutide (3-month plan): $109/month
- Compounded semaglutide (6-month plan): $99/month
- Compounded semaglutide (12-month plan): $89/month
- Compounded tirzepatide (monthly): $169/month
- Compounded semaglutide (microdose, 12-month plan): $59/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so Enhanced's $169 is genuinely below the middle, not just advertised that way. Some of Enhanced's plans are paid several months up front, so read the terms you agree to at checkout before you choose a longer one.
WellMedRx dispenses semaglutide and tirzepatide from $49/month, which makes it the fair comparison to run before you commit here.
What Enhanced dispenses
Enhanced prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy. Enhanced also lists a microdose plan, and the published evidence on GLP-1 microdosing is letters and commentary rather than trials.
Safety and disclosure
Enhanced tells you its price before you start the medical questionnaire and the pharmacy that fills its prescriptions. We found no FDA warning letters issued to Enhanced. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. The FDA publishes seven warning signs for telehealth medicine sellers, and they take a minute to run against Enhanced. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Of the peptides Enhanced sells, BPC-157, TB-500, Epitalon, Semax, KPV, and MOTS-c are among the six in the October 2026 HHS compounding policy. It says HHS does not intend to take enforcement action against 503A pharmacies that compound them under ten conditions, and it approves none of them.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Enhanced bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
Our read
Enhanced competes on price without an obvious sacrifice elsewhere: $169/month for compounded tirzepatide, no FDA warning letters.